Trump Nominates Corporate Lobbyist and Foreclosure Fraudsters Defender Pam Bondi as Attorney General
Pam Bondi has a terrible record as far as going after corporate misconduct is concerned, which explains Senate enthusiasm for her.
Read more...Pam Bondi has a terrible record as far as going after corporate misconduct is concerned, which explains Senate enthusiasm for her.
Read more...RFK, Jr.’s plan, if confirmed as HHS chair, to end Medicare use of AMA licensed-billing codes somehow will increase, not lower, costs.
Read more...The Consumer Financial Protection Bureau wants banks to send data of ex-customers to a new bank. Banks are howling. They may have a point.
Read more...Yet another example of EPA underperformance, here on the plastics pollution front.
Read more...On the considerable upset about RFK, Jr.’s nomination to head HHS.
Read more...The Wall Street Journal shows how Medicare Advantage plans curb care to sick seniors, leading many to switch to traditional Medicare
Read more...One of Trump’ inflation-cutting plans, more shale production to lower energy prices, is not going to get strong uptake from the industry.
Read more...A historical look at Presidential power grabs, um, authority expansion, with an eye to what that means under Trump 2.0.
Read more...In his new book, Mindless, historian Robert Skidelsky urges readers to reflect on the delicate balance between AI and our human essence.
Read more...Some practical ideas for how to combat climate change at the local level
Read more...More examples of how medicine, at least as practiced in the US, is going off the rails.
Read more...An important yet oft-ignored point: big and small businesses are wildly different, and that matters from a policy perspective.
Read more...Financial vehicles designed to conceal wealth and questionable activity fuel corruption and crime while allowing perps evade accountability
Read more...Following a Supreme Court ruling approving the criminalization of homelessness, many jurisdictions are imposing harsh rules and punishments.
Read more...Debunking Big Pharma whinging over Inflation Reduction Act drug price negotiations.
Read more...